Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finja Schweitzer

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis and Related Disorders|May 12, 2024
Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serumFinja Schweitzer, Anne Ladwig, Sarah Opala, et al.
Antiviral Therapy|September 14, 2010
Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolatesJens Verheyen, Finja Schweitzer, Ellen G Harrer, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 17, 2023
CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory StudyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Scientific Reports|March 4, 2024
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageFabian Boesl, Yasemin Goereci, Finja Schweitzer, et al.
Medical Microbiology and Immunology|September 21, 2010
Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patientsStefan Reuter, Mark Oette, Frank Clemens Wilhelm, et al.
BMJ Neurology Open|February 19, 2026
Impact of whole-body vibration training on gait in patients with progressive multiple sclerosis: a pilot randomised studyAgni Maria Konitsioti, Yasemin Göreci, Martin Hellmich, et al.
European Journal of Neurology|October 4, 2023
Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational studyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case ReportLea Grote-Levi, Nora Möhn, Agnes Bonifacius, et al.
Annals of Neurology|November 1, 2021
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System InfectionFinja Schweitzer, Yasemin Goereci, Christiana Franke, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 31, 2024
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)Alina Sprenger-Svačina, Ines Klein, Martin K R Svačina, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|May 12, 2024
Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serumFinja Schweitzer, Anne Ladwig, Sarah Opala, et al.
Antiviral Therapy|September 14, 2010
Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolatesJens Verheyen, Finja Schweitzer, Ellen G Harrer, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 17, 2023
CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory StudyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Scientific Reports|March 4, 2024
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageFabian Boesl, Yasemin Goereci, Finja Schweitzer, et al.
Medical Microbiology and Immunology|September 21, 2010
Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patientsStefan Reuter, Mark Oette, Frank Clemens Wilhelm, et al.
BMJ Neurology Open|February 19, 2026
Impact of whole-body vibration training on gait in patients with progressive multiple sclerosis: a pilot randomised studyAgni Maria Konitsioti, Yasemin Göreci, Martin Hellmich, et al.
European Journal of Neurology|October 4, 2023
Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational studyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case ReportLea Grote-Levi, Nora Möhn, Agnes Bonifacius, et al.
Annals of Neurology|November 1, 2021
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System InfectionFinja Schweitzer, Yasemin Goereci, Christiana Franke, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 31, 2024
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)Alina Sprenger-Svačina, Ines Klein, Martin K R Svačina, et al.
Pageof 3